Research ArticleCardiovascular
Open Access
Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers
Johann Bartko, Christian Schoergenhofer, Michael Schwameis, Patricia Wadowski, Jacek Kubica, Bernd Jilma and Eva-Luise Hobl
Journal of Pharmacology and Experimental Therapeutics May 2018, 365 (2) 430-436; DOI: https://doi.org/10.1124/jpet.117.247213
Johann Bartko
Department of Clinical Pharmacology, Medical University of Vienna (J.B., C.S., M.S., P.W., B.J., E.-L.H.), and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital of WGKK, AUVA Trauma Centre Meidling (J.B.), Vienna, Austria; and Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland (J.K.)
Christian Schoergenhofer
Department of Clinical Pharmacology, Medical University of Vienna (J.B., C.S., M.S., P.W., B.J., E.-L.H.), and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital of WGKK, AUVA Trauma Centre Meidling (J.B.), Vienna, Austria; and Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland (J.K.)
Michael Schwameis
Department of Clinical Pharmacology, Medical University of Vienna (J.B., C.S., M.S., P.W., B.J., E.-L.H.), and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital of WGKK, AUVA Trauma Centre Meidling (J.B.), Vienna, Austria; and Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland (J.K.)
Patricia Wadowski
Department of Clinical Pharmacology, Medical University of Vienna (J.B., C.S., M.S., P.W., B.J., E.-L.H.), and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital of WGKK, AUVA Trauma Centre Meidling (J.B.), Vienna, Austria; and Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland (J.K.)
Jacek Kubica
Department of Clinical Pharmacology, Medical University of Vienna (J.B., C.S., M.S., P.W., B.J., E.-L.H.), and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital of WGKK, AUVA Trauma Centre Meidling (J.B.), Vienna, Austria; and Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland (J.K.)
Bernd Jilma
Department of Clinical Pharmacology, Medical University of Vienna (J.B., C.S., M.S., P.W., B.J., E.-L.H.), and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital of WGKK, AUVA Trauma Centre Meidling (J.B.), Vienna, Austria; and Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland (J.K.)
Eva-Luise Hobl
Department of Clinical Pharmacology, Medical University of Vienna (J.B., C.S., M.S., P.W., B.J., E.-L.H.), and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital of WGKK, AUVA Trauma Centre Meidling (J.B.), Vienna, Austria; and Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland (J.K.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
Morphine and Aspirin Drug Interaction
Johann Bartko, Christian Schoergenhofer, Michael Schwameis, Patricia Wadowski, Jacek Kubica, Bernd Jilma and Eva-Luise Hobl
Journal of Pharmacology and Experimental Therapeutics May 1, 2018, 365 (2) 430-436; DOI: https://doi.org/10.1124/jpet.117.247213
Research ArticleCardiovascular
Morphine and Aspirin Drug Interaction
Johann Bartko, Christian Schoergenhofer, Michael Schwameis, Patricia Wadowski, Jacek Kubica, Bernd Jilma and Eva-Luise Hobl
Journal of Pharmacology and Experimental Therapeutics May 1, 2018, 365 (2) 430-436; DOI: https://doi.org/10.1124/jpet.117.247213
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement